Boltushka: A homemade amphetamine-type stimulant and HIV risk in Odessa, Ukraine

International Journal of Drug Policy

Volumn 20, Issue 4, 2009, Pages 347-351

  Chintalova Dallas, Repsina ^a   Case, Patricia ^a   Kitsenko, Nataliya ^b   Lazzarini, Zita ^c  

^a FENWAY INSTITUTE   (United States)

^b The Way Home Charity Fund ^*  (Ukraine)

^c UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

Amphetamine; Cathinone; Drug use; HIV; Injection drug use; Methamphetamine; Ukraine

Indexed keywords

AMPHETAMINE; AMPHETAMINE DERIVATIVE; BOLTUSHKA; CATHINONE; CENTRAL STIMULANT AGENT; ILLICIT DRUG; METHAMPHETAMINE; PERMANGANATE POTASSIUM; PHENYLPROPANOLAMINE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BRAIN DAMAGE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; DRUG ABUSE; DRUG ABUSE PATTERN; FEMALE; HARM REDUCTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; INJECTION; INTERVIEW; LEGAL ASPECT; MALE; PHARMACY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SYRINGE; UKRAINE;

ADULT; AMPHETAMINES; CENTRAL NERVOUS SYSTEM STIMULANTS; DRUG COMPOUNDING; FEMALE; HIV INFECTIONS; HUMANS; MALE; PHARMACIES; PHENYLPROPANOLAMINE; PROPIOPHENONES; RISK-TAKING; SUBSTANCE ABUSE, INTRAVENOUS; UKRAINE;

EID: 67349273599     PISSN: 09553959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugpo.2008.09.003     Document Type: Article

References (22)

1. Aretha D. Methamphetamine and amphetamines (2005), Ernslow Publishers, Inc., Berkeley Heights, NJ
2. Barcal K., Schumacher J.E., Dumchev K., and Moroz L.V. A situational picture of HIV/AIDS and injection drug use in Vinnitsya, Ukraine. Harm Reduction Journal 2 16 (2005) (11 pages open access journal, at p 5)
3. Bowler R.M., Koller W., and Schulz P.E. Parkinsonism due to manganism in a welder: Neurological and neuropsychological sequelae. Neurotoxicology 27 3. (2006) 327-332
4. Code of Ukraine on Administrative Offences. (1984). Law number 8073-X, clause 44, Illegal manufacture, purchase, possession, transportation of drug or psychotropic substances without the purpose of selling in small amounts, accepted on December 7, 1984.
5. De Bie R.M., Gladstone R.M., Strafella A.P., Ko J.H., and Lang A.E. Manganese-induced Parkinsonism associated with methcathinone (Ephedrone) abuse. Archives of Neurology 64 6 (2007) 886-889
6. Degner D., Bleich S., Riegel A., Sprung R., Poser W., and Rüther E. Follow-up study after enteral manganese poisoning: Clinical, laboratory and neuroradiological findings. Nervenarzt 71 5. (2000) 416-419
7. Egorov I. The transformation for R&D potential in Ukraine. Europe-Asia Studies 47 4 (1995) 651-668
8. Ibanez G.E., Purcell D.W., Stall R., Parsons J.T., and Gomez C.A. Sexual risk, substance use, and psychological distress in HIV-positive gay and bisexual men who also inject drugs. AIDS 19 (2005) S49-S55
9. International HIV/AIDS Alliance. (2006). Information on Ukraine. Retrieved May 24, 2007 at: http://www.aidsalliance.org/sw7229.asp.
10. Kelly J.A., and Amirkhanian Y.A. The newest epidemic: A review of HIV/AIDS in Central and Eastern Europe. International Journal of STD & AIDS 14 (2003) 361-371
11. Kuleshova E. Personal communication with psychologist at the Charity Fund (2006), The Way Home, Odessa, Ukraine
12. Matic S., Lazarus J.V., and Donoghoe M.C. HIV/AIDS in Europe: Moving from death sentence to chronic disease management (2006), WHO Regional Office for Europe
13. Meral H., Kutukcu Y., Atmaca B., Ozer F., and Hamamcioglu K. Parkinsonism caused by chronic usage of intravenous potassium permanganate. Neurologist 13 (2007) 92-94
14. Ministry of Health. (2003). Order of Ministry of Health of Ukraine from May 14, # 210; Registered in Ministry of Justice on November 5, 2003 # 1012/8333.
15. Ministry of Health. (2005). Order of the Ministry of Heath of the Ukraine date July 19, #360 (z0782-05); Registered at the Ministry of Justice of Ukraine on June 20, 2005 under the number 783/11063.
16. Novoa R.A., Ompad D.C., Wu Y., Vlahov D., and Galea S. Ecstasy use and its association with sexual behaviors among drug users in New York City. Journal of Community Health 30 (2005) 331-343
17. Rhodes T., Ball A., Stimson G.V., Kobyshcha Y., Fitch C., Pokrovsky V., et al. HIV infection associated with drug injecting in the newly independent states, eastern Europe: The social and economic context of epidemics. Addiction 94 9 (1999) 1323-1336
18. Sanotsky Y., Lesyk R., Fedoryshyn L., Komnatska I., Matviyenko Y., and Fahn S. Manganic encephalopathy due to "ephedrone" abuse. Movement Disorders 22 9 (2007) 1337-1343
19. Stepens A., Logina I., Liguts V., Aldins P., Eksteina I., Platkājis A., et al. A Parkinsonian syndrome in methcathinone users and the role of manganese. New England Journal of Medicine 358 10 (2008) 1009-1017
20. United Nations Office on Drugs and Crime (UNODC). (2004). Drugs and crime trends in Europe and beyond. Vienna: UNODC. Retrieved 24 May 2007 at: http://www.unodc.org/pdf/factsheets/unodc_factsheet_eu_29-04-2004.pdf.
21. World Bank and International HIV/AIDS Alliance. (2006). Socioeconomic impact of HIV/AIDS in Ukraine. Washington, DC. Retrieved May 24, 2007 at: http://siteresources.worldbank.org/INTUKRAINE/Resources/328335-114781240 6770/ukr_aids_eng.pdf.
22. World Health Organization (WHO). (2006). Disease control priorities related to mental, neurological, developmental and substance abuse disorders. Geneva: Disease Control Priorities Project, Department of Mental Health and Substance Abuse, WHO. Retrieved 24 May 2007 at: http://www.who.int/substance_abuse/publications/en/Neuroscience.pdf.